07:00 , May 16, 2016 |  BioCentury  |  Finance

Global ambitions

European biotechs not only missed out on the extended bull market that allowed U.S. biotechs to fill their coffers, but also on what could have been an arbitrage opportunity for U.S. investors who found domestic...
08:00 , Jan 25, 2016 |  BC Week In Review  |  Financial News

UCL financial update

The European Investment Fund (EIF) and Imperial Innovations Group plc (LSE:IVO, London, U.K.) each invested L24.8 million ($35.4 million). Albion Ventures will manage the fund. University College London, London, U.K.   Business: Finance   Date announced:...
02:11 , Jan 20, 2016 |  BC Extra  |  Financial News

UCL launches L50M fund

University College London launched the UCL Technology Fund with L50 million ($71.5 million), which it plans to invest over five years in academic research it believes has commercial potential, including licensing projects and new spinouts...
07:00 , May 25, 2015 |  BC Week In Review  |  Financial News

Abcodia completes venture financing

Abcodia Ltd., London, U.K.   Business: Diagnostic, Pharmacogenetics   Date completed: 2015-05-18   Type: Venture financing   Raised: L5.3 million ($8.2 million)   Investors: Cambridge Innovation Capital plc; Scottish Equity Partners; Albion Ventures; UCL Business plc   ...
07:00 , Apr 15, 2013 |  BioCentury  |  Emerging Company Profile

Abcodia: Banking on biomarkers

Abcodia Ltd. is using blood samples that have been taken annually by the U.K. Collaborative Trial for Ovarian Cancer Screening to identify serum biomarkers that can detect breast, lung, pancreatic and colorectal tumors at least...
08:00 , Feb 13, 2012 |  BC Week In Review  |  Financial News

Xceleron completes venture financing

Xceleron Ltd., York, U.K.   Business: Supply/Service, ADMET   Date completed: 2/6/12   Type: Venture financing   Raised: $2.4 million   Investors: Albion Ventures; Solon Ventures   ...
07:00 , May 30, 2011 |  BC Week In Review  |  Financial News

Abcodia completes venture financing

Abcodia Ltd., London, U.K.   Business: Diagnostic, Pharmacogenetics   Date completed: 5/25/11   Type: Venture financing   Raised: £1 million ($1.6 million)   Investors: Albion Ventures; UCL Business   ...